Bologna, Italy

Fabrizia Grepioni

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Fabrizia Grepioni: Innovator in Pharmaceutical Crystallization

Introduction

Fabrizia Grepioni is a notable inventor based in Bologna, Italy. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of new crystalline forms of medications. With a total of 3 patents to her name, her work has the potential to impact the treatment of various medical conditions.

Latest Patents

One of her latest patents is titled "Solvated crystal form of rifaximin, production, compositions and uses thereof." This invention describes a new crystalline form of rifaximin, characterized as a solvated form known as rifaximin <α>. The patent outlines a process for preparing rifaximin <α>, a pharmaceutical composition that includes this form, and its application in treating inflammations and infections. This innovative approach could enhance the efficacy of rifaximin in clinical settings.

Career Highlights

Throughout her career, Fabrizia has worked with prominent companies in the pharmaceutical industry, including Alfa Wassermann S.p.a. and Alfasigma S.p.a. Her experience in these organizations has allowed her to develop and refine her expertise in pharmaceutical formulations and crystallization techniques.

Collaborations

Fabrizia has collaborated with several professionals in her field, including Giuseppe Claudio Viscomi and Laura Chelazzi. These partnerships have likely contributed to her innovative research and development efforts.

Conclusion

Fabrizia Grepioni's work in the field of pharmaceutical crystallization exemplifies the importance of innovation in medicine. Her patents and collaborations highlight her commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…